Tumour-Infiltrating Lymphocytes, Tumour Cell Density, and Response to Neoadjuvant Short-Course Radiotherapy in Rectal Cancer: A Translational Sub-Study from the MRC CR07 Clinical Trial
J. Callaghan(University of Leeds), Nicholas P. West(Johannes Gutenberg University Mainz), Heike I. Grabsch(University of Leeds), Ross Jarrett(University of Leeds), Lindsay C Thompson(MRC Clinical Trials Unit at UCL), David Sebag‐Montefiore(University of Leeds), Philip Quirke(University of Leeds), Daniel Bottomley(University of Leeds), Jon Laye(University of Leeds), Alice C. Westwood(University of Leeds), Angela Meade(MRC Clinical Trials Unit at UCL), Derek Magee(University of Leeds)
Cited by 2
Related Papers
Gastric cancer
|The Lancet|2020|4.8k
Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial
|The Lancet|2009|1.5k
Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer
|Nature Medicine|2019|1.5k
Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2020|1.3k